Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (FY)Jun 30, 2025 | (FY)Jun 30, 2024 | (FY)Jun 30, 2023 | (FY)Jun 30, 2022 | (FY)Jun 30, 2021 | (FY)Jun 30, 2020 | (FY)Jun 30, 2019 | (FY)Jun 30, 2018 | (FY)Jun 30, 2017 | (FY)Jun 30, 2016 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow (direct method) | ||||||||||
| Cash income from operating activities | -52.96%1.29M | -18.39%2.73M | 175.25%3.35M | 63.50%1.22M | -1.50%743.78K | -79.28%755.14K | 995.43%3.64M | -65.90%332.71K | 82.10%975.8K | -74.42%535.85K |
| Revenue from customers | ---- | ---- | ---- | --27.5K | ---- | 0.00%27.5K | 0.00%27.5K | --27.5K | ---- | ---- |
| Income from government grants | ---- | ---- | ---- | ---- | 110.82%117K | -9.01%55.5K | 390.52%61K | -18.94%12.44K | --15.34K | ---- |
| Other cash income from operating activities | -52.96%1.29M | -18.39%2.73M | 181.62%3.35M | 89.63%1.19M | -6.75%626.78K | -81.10%672.14K | 1,114.62%3.56M | -69.52%292.78K | 79.24%960.46K | -74.39%535.85K |
| Cash paid | 33.75%-3.08M | 49.47%-4.65M | 7.10%-9.2M | -114.26%-9.91M | -39.08%-4.62M | 14.21%-3.32M | -58.12%-3.88M | -5.97%-2.45M | -8.34%-2.31M | 66.50%-2.13M |
| Payments to suppliers for goods and services | 33.75%-3.08M | 49.47%-4.65M | 7.10%-9.2M | -114.26%-9.91M | -39.08%-4.62M | 14.21%-3.32M | -58.12%-3.88M | -5.97%-2.45M | -8.34%-2.31M | 66.50%-2.13M |
| Direct interest received | -78.85%21.8K | 34.25%103.09K | 597.43%76.79K | 323.79%11.01K | -96.48%2.6K | -27.30%73.75K | 222.61%101.45K | -47.69%31.45K | -11.25%60.12K | -59.07%67.74K |
| Operating cash flow | 2.30%-1.77M | 68.58%-1.82M | 33.42%-5.78M | -123.86%-8.68M | -55.36%-3.88M | -1,831.75%-2.5M | 93.81%-129.19K | -63.41%-2.09M | 16.61%-1.28M | 62.78%-1.53M |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | 0 | 0.68%1.01M | -49.84%1M | 149.79%1.99M | -4M | 199.59%2M | -72,224.97%-2M | -104.32%-2.77K | 146.54%64.07K | |
| Net PPE purchase and sale | ---- | ---3.24K | ---- | 41.11%-2.29K | ---3.89K | ---- | 1.53%-4.06K | -48.86%-4.13K | -104.32%-2.77K | 6,637.43%64.07K |
| Net investment purchase and sale | ---- | 1.00%1.01M | -49.90%1M | 149.90%2M | ---4M | ---- | 200.00%2M | ---2M | ---- | ---- |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | --0 | 0.68%1.01M | -49.84%1M | 149.79%1.99M | ---4M | ---- | 199.59%2M | -72,224.97%-2M | -104.32%-2.77K | 146.54%64.07K |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | 6,326.69%275.96K | -33.40%4.29K | -99.91%6.45K | -31.63%7.56M | 11.05M | -99.97%1.8K | 6.82M | |||
| Net common stock issuance | 6,326.69%275.96K | -33.40%4.29K | -99.91%6.45K | -31.63%7.56M | --11.05M | ---- | -99.97%1.8K | --6.82M | ---- | ---- |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | 6,326.69%275.96K | -33.40%4.29K | -99.91%6.45K | -31.63%7.56M | --11.05M | ---- | -99.97%1.8K | --6.82M | ---- | ---- |
| Net cash flow | ||||||||||
| Beginning cash position | -26.43%2.24M | -61.04%3.05M | 13.03%7.82M | 73.73%6.92M | -38.50%3.98M | 40.57%6.47M | 141.00%4.61M | -40.56%1.91M | -30.81%3.22M | -46.24%4.65M |
| Current changes in cash | -86.15%-1.5M | 83.14%-804.86K | -647.97%-4.77M | -72.53%870.92K | 227.05%3.17M | -233.55%-2.5M | -31.44%1.87M | 312.96%2.73M | 12.78%-1.28M | 65.50%-1.47M |
| Effect of exchange rate changes | ---- | ---- | -99.84%50 | 112.90%30.32K | -8,220.17%-235.08K | 1,783.14%2.9K | 99.44%-172 | -26.96%-30.9K | -167.98%-24.34K | -85.99%35.8K |
| End cash Position | -66.87%742.44K | -26.43%2.24M | -61.04%3.05M | 13.03%7.82M | 73.73%6.92M | -38.50%3.98M | 40.57%6.47M | 141.00%4.61M | -40.56%1.91M | -30.81%3.22M |
| Free cash from | 2.47%-1.77M | 68.52%-1.82M | 33.44%-5.78M | -123.69%-8.68M | -55.52%-3.88M | -1,772.86%-2.5M | 93.63%-133.25K | -63.38%-2.09M | 16.70%-1.28M | 63.90%-1.54M |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |